Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5271395
Max Phase: Preclinical
Molecular Formula: C30H44Br2N10O4
Molecular Weight: 768.56
Associated Items:
ID: ALA5271395
Max Phase: Preclinical
Molecular Formula: C30H44Br2N10O4
Molecular Weight: 768.56
Associated Items:
Canonical SMILES: COc1c(Br)cc(C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCc2ccccc2)cc1Br
Standard InChI: InChI=1S/C30H44Br2N10O4/c1-46-25-20(31)15-19(16-21(25)32)17-24(42-26(43)22(33)9-5-12-39-29(34)35)28(45)41-23(10-6-13-40-30(36)37)27(44)38-14-11-18-7-3-2-4-8-18/h2-4,7-8,15-16,22-24H,5-6,9-14,17,33H2,1H3,(H,38,44)(H,41,45)(H,42,43)(H4,34,35,39)(H4,36,37,40)/t22-,23-,24-/m0/s1
Standard InChI Key: QDBQJEIICWWEIN-HJOGWXRNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 768.56 | Molecular Weight (Monoisotopic): 766.1914 | AlogP: 0.95 | #Rotatable Bonds: 19 |
Polar Surface Area: 246.35 | Molecular Species: BASE | HBA: 7 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.58 | CX Basic pKa: 12.06 | CX LogP: 0.39 | CX LogD: -4.35 |
Aromatic Rings: 2 | Heavy Atoms: 46 | QED Weighted: 0.06 | Np Likeness Score: 0.17 |
1. Craig AJ, Ermolovich Y, Cameron A, Rodler A, Wang H, Hawkes JA, Hubert M, Björkling F, Molchanova N, Brimble MA, Moodie LWK, Svenson J.. (2023) Antimicrobial Peptides Incorporating Halogenated Marine-Derived Amino Acid Substituents., 14 (6): [PMID:37312845] [10.1021/acsmedchemlett.3c00093] |
Source(1):